Jpmorgan Chase & CO Ark Genomic Revolution ETF (De Transaction History
Jpmorgan Chase & CO
- $1.51 Trillion
- Q3 2025
A detailed history of Jpmorgan Chase & CO transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Jpmorgan Chase & CO holds 3,943,913 shares of ARKG stock, worth $106 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,943,913
Previous 3,943,913
-0.0%
Holding current value
$106 Million
Previous $110 Million
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
20 transactions
Others Institutions Holding ARKG
# of Institutions
297Shares Held
20.3MCall Options Held
2.53MPut Options Held
2.8M-
Morgan Stanley New York, NY2.83MShares$76.2 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.16MShares$58.1 Million0.01% of portfolio
-
Citigroup Inc1.52MShares$40.8 Million0.02% of portfolio
-
Ubs Group Ag1.12MShares$30.1 Million0.01% of portfolio
-
Wells Fargo & Company San Francisco, CA997KShares$26.8 Million0.01% of portfolio